Cargando…

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy

Detalles Bibliográficos
Autores principales:	Shen, Hongru, Shen, Xilin, Wu, Dan, Feng, Mengyao, Yang, Yichen, Li, Yang, Yang, Meng, Wang, Wei, Zhang, Qiang, Song, Fangfang, Chen, Kexin, Li, Xiangchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752154/ https://www.ncbi.nlm.nih.gov/pubmed/33377654 http://dx.doi.org/10.1002/ctm2.238

Ejemplares similares

Prediction of Two Molecular Subtypes of Gastric Cancer Based on Immune Signature
por: Wu, Dan, et al.
Publicado: (2022)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis
por: Shen, Xilin, et al.
Publicado: (2021)

Miscell: An efficient self-supervised learning approach for dissecting single-cell transcriptome
por: Shen, Hongru, et al.
Publicado: (2021)

Generative pretraining from large-scale transcriptomes for single-cell deciphering
por: Shen, Hongru, et al.
Publicado: (2023)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
por: Bartee, Eric, et al.
Publicado: (2017)

Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end?
por: Peng, Ling, et al.
Publicado: (2021)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

An efficient context-aware approach for whole-slide image classification
por: Shen, Hongru, et al.
Publicado: (2023)

PD-1 immune checkpoint blockade may be viable for the prevention and treatment of elderly patients with POCD [Letter]
por: Wei, Penghui, et al.
Publicado: (2019)

Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
por: Yan, Chi, et al.
Publicado: (2021)

High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
por: Wang, Qinghua, et al.
Publicado: (2020)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
por: Yang, Chenxuan, et al.
Publicado: (2021)

Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies
por: Shen, Hongxing, et al.
Publicado: (2019)

SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
por: Di Giacomo, Anna M., et al.
Publicado: (2020)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
por: Jin, Ying, et al.
Publicado: (2020)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade
por: Luo, Hao, et al.
Publicado: (2022)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

Cyclic adenosine monophosphate potentiates immune checkpoint blockade therapy in acute myeloid leukemia
por: Mao, Ping, et al.
Publicado: (2023)

Letter Regarding “Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma”
por: Wang, Yinhan, et al.
Publicado: (2022)

Expression patterns of immune checkpoints in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2020)

Immunomodulatory effects of cigarette smoke condensate in mouse macrophage cell line
por: Zhao, Junwei, et al.
Publicado: (2017)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
por: Zhao, Jun, et al.
Publicado: (2019)

Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
por: Li, Si-Qi, et al.
Publicado: (2022)

Immune checkpoint inhibitors: friend or foe for osteoporosis
por: Tang, Jun
Publicado: (2023)

Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention
por: Li, Xinya, et al.
Publicado: (2023)

Effect of administering subsequent immune checkpoint inhibition in cancer patients with prior COVID-19 infection
por: Bi, Jianping, et al.
Publicado: (2021)

Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade
por: Yoo, Seong-Keun, et al.
Publicado: (2022)

A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer
por: Jin, Fangfang, et al.
Publicado: (2021)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment
por: Wang, Zhenghang, et al.
Publicado: (2020)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
por: Zeng, Zhirui, et al.
Publicado: (2022)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8eivdhkojpohbj18kfaj72ar5q